logo

Bellerophon Therapeutics Llc (BLPH)



Trade BLPH now with
  Date
  Headline
5/10/2018 8:47:57 AM Bellerophon Therapeutics Q1 Net Income $4.1 Mln Or $0.07/shr Vs Net Loss Of $19.1 Mln Or $0.60/shr Prior Year
5/8/2018 8:36:11 AM Bellerophon Reaches Agreement With FDA On Study Design Of Phase 2b Trial Of INOpulse
1/3/2018 8:35:48 AM Bellerophon Announces First Patient Enrolled In Phase 2b Study Evaluating INOpulse
11/7/2017 8:38:55 AM Bellerophon Q3 Net Loss $7.6 Mln Or $0.22 Per Share
9/27/2017 8:30:42 AM Bellerophon Announces $23.4 Mln Private Placement
9/5/2017 8:34:58 AM Bellerophon Announces Positive Top Line Phase 2 Data Of INOpulse
8/7/2017 8:13:07 AM Bellerophon Therapeutics Q2 Net Loss Per Share $0.12 Vs Loss Of $0.39 Prior Year
8/3/2017 8:34:49 AM Bellerophon Announces FDA Agreement On Phase 2b Study Design For INOpulse In PH-ILD